Hagen Kennecke
@hkennecke
GI and NET Oncologist, @OHSU Knight Cancer Institute, Chief & Med Dir CHO and Knight-Legacy Collaborative, Dad, cycling & ski enthusiast!
ID: 2378288102
08-03-2014 06:54:27
1,1K Tweet
1,1K Followers
445 Following
First prospective trial to confirm benefit of adjuvant COX-2 in PIK3CA activated #coloncancer, OS HR=0.4. Patients are asking: do we recommend COX-2 for the 20% with mut PIK3CA❓ Need to do NGS for all stage III CRC. Journal of Clinical Oncology
